CRISPR/Cas9-mediated deletion of miR-146a enhances antiviral response in HIV-1 infected cells.

CRISPR/Cas9-mediated deletion of miR-146a enhances antiviral response in HIV-1 infected cells.
复制标题

CRISPR/Cas9 介导的 miR-146a 缺失增强了 HIV-1 感染细胞的抗病毒反应。

DOI:
10.1038/s41435-018-0036-x
复制
发表时间:
2018
期刊:
Genes Immun
影响因子:
--
通讯作者:
Feng Yong
Feng Yong
中科院分区:
其他
文献类型:
--
作者:
Teng Yan;Luo Mingqi;Yu Ting;Chen Lang;Huang Qiuling;Chen Shuliang;Xie Linlin;Zeng Yan;Luo Fan;Xiong Hairong;Liu Yuanyuan;Hou Wei;Feng Yong

文献摘要

被引文献

相似文献

人类免疫缺陷病毒1型(human immunodeficiency virus type 1,HIV-1)在人体内引起持续感染,并诱导感染细胞中miR-146 a表达。miR-146 a通过抑制TRAF 6和IRAK 1基因的表达,抑制天然免疫应答,从而负性调控NF-κ B相关的细胞因子和干扰素刺激基因。在此,我们报道了慢病毒CRISPR/Cas9系统在前体miR-146 a基因组序列中高效引入突变,导致miR-146 a表达和功能丧失。miR-146 a消融导致LPS刺激的A549细胞中细胞因子产生增加。此外,miR-146 a敲除在HIV-1感染的MT 2细胞中显著增加细胞因子和HIV-1限制性因子的表达,并逆转T细胞耗竭标记物的表达,从而影响HIV-1复制。我们的研究表明,慢病毒CRISPR/Cas9介导的基因编辑是消除miR-146 a表达的有效方法,从而通过增强细胞因子和HIV-1限制因子的表达来抑制HIV-1复制以及前病毒再激活。
The human immunodeficiency virus type 1 (HIV-1) causes persistent infection in human and induces miR-146a expression in infected cells. miR-146a represses the innate immune response by inhibiting the expression ofTRAF6andIRAK1genes, thus negatively controls the NF-κB-related cytokines and interferon stimulated genes. Here we reported that lentiviral CRISPR/Cas9 system was highly efficient in introducing mutations in the precursor miR-146a genomic sequences, resulting in a loss of miR-146a expression and function. miR-146a ablation led to increasing cytokines production in LPS-stimulated A549 cells. Moreover, miR-146a knockout in HIV-1 infected MT2 cells markedly increased the expression of cytokines and HIV-1 restriction factors and reversed T cell exhaustion markers expression, thus influencing HIV-1 replication. Our study indicates that lentiviral CRISPR/Cas9-mediated gene editing is an effective approach to abrogate miR-146a expression, which consequently inhibits HIV-1 replication as well as proviral reactivation by enhancing the expression of cytokines and HIV-1 restriction factors.